Spasmogenic effects of the anti-fertility agent, zoapatanol.
D000019:Abortifacient Agents / Q000494:pharmacology*; D000818:Animals; D001158:Arteries; D001681:Biological Assay / Q000379:methods; D002415:Cats; D003270:Contraceptive Agents / Q000494:pharmacology*; D003331:Coronary Vessels / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007082:Ileum / Q000187:drug effects; D008297:Male; D035924:Montanoa; D009130:Muscle, Smooth / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D010082:Oxepins / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D014599:Uterus / Q000187:drug effects
D000019:Abortifacient Agents; D003270:Contraceptive Agents; D010082:Oxepins; C442248:zoapatanol